Alphatec Holdings, Inc., through its wholly-owned subsidiary Alphatec Spine, Inc., is a medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company’s mission is to improve lives by providing innovative spine surgery solutions through the relentless pursuit of superior outcomes. The company markets its products in the U.S. via independent sales agents and a direct sales force.
Alphatec’s principal product offering includes a wide variety of spinal solutions comprised of components such as access systems, interbody implants, fixation plates, thoracolumbar and cervico/thoracic screws and rods, best-in-class instruments, and various biologics offerings all designed to enhance and promote spinal fusion. The business is focused on treating conditions from degenerative to complex deformity and trauma through a variety of MIS and traditional procedures.
InnovaHealth Partners’ predecessor firm, HealthpointCapital, initially invested in Alphatec Spine in 2005. Mortimer Berkowitz III currently serves as Lead Director of Alphatec Spine, Inc.